| Kimberly Marie Seheult, M ED, MHP, LAPC | |
|
2055 Barrett Lakes Blvd, Apt 1402, Kennesaw, GA 30144 | |
| (404) 693-1559 | |
| (404) 745-0271 |
| Full Name | Kimberly Marie Seheult |
|---|---|
| Gender | Female |
| Speciality | Behavior Analyst |
| Location | 2055 Barrett Lakes Blvd, Kennesaw, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053636860 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | APC002550 (Georgia) | Secondary |
| 103K00000X | Behavior Analyst | APC002550 (Georgia) | Primary |
| 103TC1900X | Psychologist - Counseling | APC002550 (Georgia) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Marie Seheult, M ED, MHP, LAPC 2055 Barrett Lakes Blvd, Apt 1402, Kennesaw, GA 30144 Ph: (404) 693-1559 | Kimberly Marie Seheult, M ED, MHP, LAPC 2055 Barrett Lakes Blvd, Apt 1402, Kennesaw, GA 30144 Ph: (404) 693-1559 |
News Archive
UCB Canada Inc. is proud to announce the launch of the 2010 UCBeyond Scholarship Program. During its four-year lifespan, the UCBeyond Scholarship has allocated almost 70 educational bursaries worth close to $350,000.00 CAN to students living with chronic illnesses such as rheumatoid arthritis, Crohn's disease and epilepsy.
International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.
New research suggests that universal intimate partner violence (IPV) screening in health care settings does not result in significant changes in subsequent reports of IPV or quality of life, according to a study in the August 5 issue of JAMA, a theme issue on violence and human rights.
Columbia University Medical Center researchers have captured the first three-dimensional snapshots of the AMPA-subtype glutamate receptor in action. The receptor, which regulates most electrical signaling in the brain, is involved in several important brain activities, including memory and learning.
Blue Chip Patient Recruitment, a division of Blue Chip Marketing Worldwide, a full-service integrated marketing agency, has successfully partnered with Orexigen Therapeutics to accelerate patient enrollment of The Light Study, Orexigen's cardiovascular outcomes trial evaluating Contrave (naltrexone sustained release (SR)/bupropion SR).
› Verified 1 days ago